Semaglutide
The revolutionary once-weekly GLP-1 medication that helps your body feel full faster and longer, leading to significant weight loss while also protecting your heart—FDA approved and backed by some of the largest clinical trials in obesity medicine history.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team
Suggested dose
0.25 – 2.4 mg
0.25 mg
4 weeks
0.5-1 mg
At least 4 weeks at each step
2-2.4 mg
Ongoing/maintenance
Compound profile
Scientific & efficacy data
Weight Management
Peptide profile
Strong human trials
Semaglutide
0.25 mg · Once weekly
Molecular formula
C187H291N45O59
- Mol. weight
- 4113.58 g/mol
- CAS number
- 910463-68-2
- PubChem
- 56843331
- Developed · 2012
- Lotte Bjerre Knudsen and team
Novo Nordisk
Amino acid sequence
His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(C18 fatty diacid-γGlu-OEG-OEG)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-GlyWeight Loss
Produces 15%+ average body weight loss in clinical trials—among the most effective non-surgical weight loss interventions ever studied [1][9]
Appetite Control
Dramatically reduces hunger and food cravings by mimicking natural satiety hormones, making portion control feel effortless rather than forced [3][7][13]
Heart Protection
Proven 20% reduction in cardiovascular events (heart attacks, strokes, CV death) in the SELECT trial—a first for weight loss medications [2]
Dosing
How much do I take?
0.25 mg, titrated to 2-2.4 mg · once weekly · subcutaneous
0.25 – 2.4 mg
Once weekly
Covers all 6 documented dose levels · 2 administration routes · timing · dose-adjustment guidance.
Suitability
Is this right for me?
Best for significant weight loss & long-term weight management
Best for
People with Obesity Seeking Significant Weight Loss
If your BMI is 30 or higher (or 27+ with weight-related health conditions), semaglutide is currently one of the most effective non-surgical weight loss options available. [7] Clinical trials show average weight loss of 15% of body weight—that's 30+ pounds for someone starting at 200 pounds [1].
Those Who've Struggled with Diet and Exercise Alone
Semaglutide works by changing the biological signals that drive hunger and cravings. If you've tried to lose weight through willpower alone and found yourself constantly battling hunger, this medication addresses that underlying biology rather than just telling you to eat less [3][7][13].
People with Type 2 Diabetes Needing Better Control
Originally developed for diabetes, semaglutide excellently controls blood sugar while also promoting weight loss—addressing two major health concerns simultaneously. [3][5] It can often allow people to reduce or eliminate other diabetes medications [21].
Individuals at High Cardiovascular Risk
The SELECT trial proved that semaglutide reduces heart attacks, strokes, and cardiovascular death by 20% in people with obesity and existing heart disease—even without diabetes. It's one of the few weight loss medications proven to improve hard cardiovascular outcomes [2].
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Semaglutide with similar peptides to find the best fit for your goals.
Administration
How do I use it?
Subcutaneous injection · Oral tablet
Route
Subcutaneous injection (into the fatty tissue just under the skin)—quick, relatively painless, and can be self-administered at home
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is it safe?
4 common side effects · 3 serious
Semaglutide has been studied in over 20,000 participants across multiple large clinical trials, making it one of the most thoroughly researched weight loss medications available.
[1][2][8][9][10] The FDA approved it after rigorous review of safety data. While GI side effects are common (especially early on), serious side effects are rare. [1][7] The SELECT trial showed it actually reduces cardiovascular events, adding a safety benefit beyond just weight loss [2].
The safety profile is supported by multiple Phase 3 trials including STEP 1-4 (weight loss) and SELECT (cardiovascular outcomes), with follow-up extending to nearly 4 years. [1][2][8][9][10] Long-term studies continue, and post-marketing surveillance actively monitors for rare adverse events.
The thyroid tumor signal seen in rodents has not been confirmed in humans after years of widespread use [7][15].
Common side effects · experienced by some users
Nausea
The most frequently reported side effect, affecting about 44% of users at higher doses. [7] Usually worst during the first few weeks and when increasing doses, then typically improves significantly [1].
Management: Eat smaller meals, avoid fatty or fried foods, stay upright after eating, and consider ginger or peppermint tea. The slow dose escalation protocol specifically minimizes this. If severe, your doctor may slow the dose increases.
Constipation or Diarrhea
GI motility changes are common as semaglutide slows stomach emptying. Some people experience constipation, others diarrhea, and some alternate between both [7].
Management: Stay well hydrated, increase fiber intake gradually, and maintain physical activity. Over-the-counter remedies like stool softeners (for constipation) or anti-diarrheals can help. Symptoms usually improve over time.
Decreased Appetite
This is actually how semaglutide works—it's a feature, not a bug. You'll naturally want to eat less and feel full faster. Some people find this dramatic enough that they forget to eat [3][7].
Management: While reduced appetite is the goal, make sure you're still eating regular nutritious meals. Focus on protein and vegetables at each meal. Skipping meals entirely can lead to muscle loss and nutritional deficiencies.
Vomiting
About 24% of users experience vomiting, especially during dose increases. [7] Like nausea, it's typically transient and improves as your body adjusts [1].
Management: Eat bland foods, avoid lying down after meals, and stay hydrated. If vomiting is frequent, contact your healthcare provider—they may recommend staying at the current dose longer before increasing.
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe or persistent nausea and vomiting that prevents adequate nutrition despite dose adjustments
- Signs of pancreatitis—severe abdominal pain radiating to the back
- Allergic reaction—rash, itching, swelling, difficulty breathing
- Signs of thyroid tumors—neck lump, hoarseness, trouble swallowing
- Pregnancy or planning to become pregnant (stop at least 2 months before conception)
- Severe kidney problems or dehydration from GI symptoms
- Your healthcare provider recommends discontinuation
Semaglutide is a prescription medication that should only be started, adjusted, or stopped under medical supervision. This information is educational and does not replace professional medical advice. Stopping suddenly is generally safe, but discuss any changes with your healthcare provider.
With other peptides
- Caution:Other GLP-1 Agonists (liraglutide, tirzepatide) — Never combine GLP-1 medications—they work through the same mechanism and combining would increase side effects without additional benefit.
- Safe:BPC-157 — No direct interaction data exists. BPC-157 is sometimes used for GI healing, which could theoretically help with semaglutide's GI side effects, but this is speculative.
- Safe:Growth Hormone Peptides — Limited interaction data. Some users combine them, but this should be done under medical supervision as both can affect glucose metabolism.
With medications
- Caution:Insulin — Semaglutide enhances insulin's blood sugar-lowering effect. Insulin doses typically need to be reduced 20-50% when starting semaglutide to prevent hypoglycemia. Work closely with your doctor.
- Caution:Sulfonylureas (glipizide, glyburide) — High risk of hypoglycemia when combined. Sulfonylurea dose usually needs reduction. Monitor blood sugar closely.
- Safe:Oral Contraceptives — Semaglutide's effect on gastric emptying may affect absorption of oral medications. Consider taking birth control at a consistent time relative to meals, or discuss alternative contraception.
- Safe:Warfarin — May affect warfarin absorption and metabolism. More frequent INR monitoring recommended when starting or changing semaglutide doses.
- Safe:Levothyroxine — Take thyroid medication on an empty stomach as usual. Semaglutide shouldn't significantly affect absorption if taken at different times.
With supplements
- Safe:Vitamin B12 — Long-term GLP-1 use may reduce B12 absorption. Consider B12 supplementation, especially if you've been on semaglutide for over a year.
- Safe:Fiber Supplements — Can help manage constipation from semaglutide. Start slowly to avoid worsening GI symptoms. Psyllium husk is a good option.
- Safe:Protein Supplements — Helpful for ensuring adequate protein intake when appetite is reduced. Aim for at least 60-80g protein daily to preserve muscle mass during weight loss.
- Safe:Probiotics — May help with GI side effects. Some users find them helpful for digestive comfort during semaglutide therapy.
Effectiveness
How do I know it's working?
Strong human trials · first signs weeks 1-4 (0.25mg dose)
Evidence level
Strong human trials
(Phase 3 or FDA approved)
Regulatory status
FDA approved for this use
Onset of effects
Moderate
(1-2 weeks)
How it works
Imagine your gut has a 'fullness hormone' called GLP-1 that tells your brain when you've eaten enough.
The problem is, this natural hormone only lasts a few minutes before breaking down. [3] Semaglutide is like a super-powered, long-lasting version of that hormone. It's been modified so it stays active in your body for a whole week instead of minutes.
When you take it, your brain gets a continuous 'I'm satisfied' signal, making you naturally want to eat less. It also slows down how fast food leaves your stomach, so you feel full longer after smaller meals. [7] The result?
You lose weight because you're genuinely less hungry—not because you're white-knuckling through deprivation.
The deeper mechanism
Semaglutide is a GLP-1 receptor agonist with 94% homology to native human GLP-1, featuring key modifications: an amino acid substitution at position 8 (Ala→Aib) providing DPP-4 resistance, and acylation with an 18-carbon fatty diacid chain attached via a spacer at Lys26, enabling non-covalent albumin binding.
[7][12] This results in a half-life of approximately 168 hours (vs. 2-3 minutes for native GLP-1), allowing once-weekly dosing.
[3][7] Mechanistically, semaglutide activates GLP-1 receptors in multiple tissues: pancreatic beta cells (glucose-dependent insulin secretion), pancreatic alpha cells (glucagon suppression), gastric mucosa (delayed gastric emptying), and hypothalamic neurons (appetite suppression via POMC/CART activation and NPY/AgRP inhibition).
[13] The weight loss effects primarily derive from central nervous system actions reducing hunger, increasing satiety, and decreasing food reward signals.
Cardiovascular benefits appear multifactorial, involving direct vascular effects, anti-inflammatory actions (reduced hsCRP), improved lipid profiles, and secondary effects from weight loss and glycemic improvement [1][2][22].
What to expect
Weeks 1-4 (0.25mg dose)
What you might notice
- Mild nausea, especially after eating larger meals
- Possibly feeling full slightly faster than usual
- Minimal to no weight loss yet—this is the adjustment phase
- Some people feel nothing at this dose, which is completely normal
What's normal
- GI symptoms that come and go
- Still feeling hungry between meals
- Weight staying roughly the same
- Getting used to the injection routine
What's next
- After 4 weeks, increase to 0.5mg
- Continue eating normally—don't force portion changes yet
- Establish your weekly injection routine
Weeks 5-12 (0.5-1.0mg doses)
What you might notice
- Noticeably reduced appetite and food thoughts
- Feeling full on smaller portions
- Weight loss beginning—typically 2-4 pounds in first month at effective doses
- GI side effects may temporarily increase with each dose increase, then improve
What's normal
- Nausea for a few days after dose increases
- Smaller meals feeling satisfying
- Early weight loss, though amounts vary widely between people
- Reduced interest in snacking or large portions
What's next
- Continue gradual dose increases every 4 weeks
- Start focusing on protein-rich, nutrient-dense foods
- Notice how your relationship with food is changing
Weeks 13-20 (1.7-2.4mg doses)
What you might notice
- Significant appetite suppression—may need reminders to eat
- Steady weight loss of 1-2 pounds per week
- Food cravings much more manageable
- GI symptoms typically stabilizing at this point
What's normal
- Eating 30-50% less than before without feeling deprived
- Less interest in formerly tempting foods
- Clothes fitting looser, physical changes becoming visible
- Improved energy as weight comes off
What's next
- Reach and maintain the 2.4mg dose for ongoing weight management
- Focus on building sustainable eating habits
- Add or increase physical activity as comfortable
Months 6-12 and beyond
What you might notice
- Approaching or reaching weight loss goals (average 15% of starting weight)
- Metabolic improvements visible on lab work
- New relationship with food and eating habits established
- Side effects typically minimal or absent at this stage
What's normal
- Weight loss slowing as you approach a new steady state
- Maintaining reduced appetite at the 2.4mg dose
- Lab improvements in blood sugar, cholesterol, inflammation markers
- Needing to update wardrobe multiple times
What's next
- Continue maintenance therapy—weight typically returns if medication is stopped
- Work with your doctor on long-term plan
- Focus on lifestyle habits that support maintaining your progress
Signs it's working
Appetite and Eating Behavior
- Feeling satisfied with smaller portions
- Fewer food cravings, especially for sweets and fatty foods
- Reduced 'food noise'—less constant thinking about food
- Natural tendency to choose healthier options
- No longer feeling controlled by hunger
Weight and Body Composition
- Scale weight consistently trending downward
- Clothes fitting looser, needing smaller sizes
- Visible changes in face, waist, and other areas
- Waist circumference decreasing
- Progress photos showing clear differences
Health Markers (via lab tests)
- Blood sugar levels improving (especially HbA1c for diabetics)
- Blood pressure decreasing toward normal
- Cholesterol panel improving (lower LDL, triglycerides)
- Reduced inflammatory markers (hsCRP)
- Liver enzymes improving if previously elevated
Not seeing results? Common reasons
- Not at therapeutic dose yet—most weight loss happens at 1.7-2.4mg doses; lower starting doses are for adjustment
- Not waiting long enough—significant results typically take 3-6 months of consistent use at full doses
- Eating through the medication—forcing yourself to eat large portions despite feeling full defeats the mechanism
- Choosing calorie-dense foods—smaller portions of high-calorie foods can still prevent weight loss
- Underlying metabolic conditions—thyroid disorders, PCOS, or medications like steroids may slow progress
- Dehydration affecting the scale—make sure you're drinking enough water for accurate weight readings
Key research
Clinical trials
Tested in people
755 registered studies, 259 still enrolling.
By phase
A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.
What kind of research
About 236,836 people took part in the studies that actually administered Semaglutide. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.
Most recent
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
Ludwig-Maximilians - University of Munich
GLP-1 RA for Stage 1 Type 1 Diabetes
Children's Hospital Medical Center, Cincinnati
Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
Knut Mai
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when Semaglutide is named as an intervention; studies that only mention it in passing are not.
Questions
Frequently asked
How much weight will I actually lose on semaglutide?
Clinical trials showed an average of about 15% of body weight over 68 weeks—that's roughly 35 pounds for someone starting at 230 pounds. But results vary widely: about 30% of people lose more than 20% of their weight, while some lose less. Diet quality, physical activity, and individual biology all play roles [1].
Why do I have to start at such a low dose?
The gradual dose escalation isn't about being cautious—it's essential for tolerability. Starting at the full dose would cause severe nausea and vomiting in most people. The 4-week increases let your GI system adapt gradually, making side effects much more manageable. Patience during this phase pays off [5][7].
What happens if I stop taking semaglutide?
Most people regain significant weight after stopping—studies show about two-thirds of lost weight returns within a year. [11] This isn't a moral failing; it's biology. The medication is treating the underlying metabolic and neurological drivers of obesity, and those return when the medication stops. Most people need long-term treatment [10].
Is semaglutide safe long-term?
Current data from clinical trials extending to 4+ years shows a consistent safety profile. [2][7] The SELECT trial followed patients for an average of 40 months and showed cardiovascular benefits, not harms. That said, it's a relatively new medication (approved 2017 for diabetes, 2021 for obesity), [3] and longer-term monitoring continues.
Will I lose muscle along with fat?
Some muscle loss occurs with any significant weight loss, including with semaglutide—roughly 25-40% of weight lost may be lean mass. [18] To minimize this: prioritize protein (aim for 1g per pound of goal body weight), include resistance training, and ensure adequate total nutrition. Don't skip meals just because you're not hungry.
Can I drink alcohol on semaglutide?
Alcohol isn't contraindicated, but many users find their tolerance decreases significantly. Alcohol can also worsen nausea and GI side effects, lower blood sugar (especially in diabetics), and provides empty calories that can slow weight loss. Most people naturally drink less [19] because it just doesn't appeal to them as much.
Why is there a thyroid cancer warning?
In rodent studies, semaglutide and other GLP-1 drugs caused thyroid C-cell tumors. [7] However, rodents have many more GLP-1 receptors in their thyroid than humans. [14] After years of widespread human use (millions of prescriptions), no clear increase in thyroid cancer has been seen. [15] Still, it's contraindicated if you have a personal or family history of medullary thyroid cancer.
What's the difference between Ozempic and Wegovy?
They're both semaglutide, just different doses and indications. Ozempic (max 2mg/week) is FDA-approved for type 2 diabetes. Wegovy (max 2.4mg/week) is FDA-approved for chronic weight management. If you don't have diabetes and want it primarily for weight loss, Wegovy is the appropriate product, though both cause weight loss [5][7].
Further reading
History & related research
Studied for
Ready for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Semaglutide, on one page.